솔레센스SLSN 주가

Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition

The report, led by the United Kingdom’s APPG for Beauty, Hair & Wellbeing, calls for a national strategy to combat UV exposure, including Government support to enable access to adequate protection, build public awareness and combat misinformation. From left the photo includes: Carolyn Harris, MP, Chair of the APPG for Beauty, Hair & Wellbeing, Victoria Brownlie MBE, Chief Policy & Sustainability Officer, British Beauty Council, Emma Harper, Executive Director, Strategy, Marketing, and Communicat

Solesence Inc (SLSN) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...

Solesence Inc (SLSN) reports a revenue dip but remains optimistic about future growth through new technologies and improved operational strategies.

Solesence, Inc. Common Stock Q1 2026 Earnings Call Summary

Moby summary of Solesence, Inc. Common Stock's Q1 2026 earnings call

Gross Margin Expansion Highlights Solésence’s Operational Restructuring Efforts (SLSN)

Solésence reported improved gross margin in the first quarter despite lower revenue and a return to a net loss, as the company continued executing its Transform & Transcend strategic initiative. Key Investor TakeawaysSolésence (NASDAQ:SLSN) posted first-quarter revenue of $13.

♻️ 재탕Solesence, Inc. (SLSN) Q1 2026 Earnings Call Transcript

Solesence, Inc. (SLSN) Q1 2026 Earnings Call May 12, 2026 8:30 AM EDTCompany ParticipantsKevin Cureton - President, CEO & DirectorLaura Riffner - Chief...

Transcript : Solesence, Inc., Q1 2026 Earnings Call, May 12, 2026

Presentation Operator MessageOperator Good day, and thank you for standing by. Welcome to the Solesence First Quarter 2026 Conference Call. Today's call is being recorded. On today's call, we have...

Solésence Reports First Quarter 2026 Financial Results

Advances implementation of Transform and Transcend strategic initiative across Operational Excellence and New Technology Commercialization ROMEOVILLE, Ill., May 12, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the first quarter ended March 31, 2026. “In March, we introduced Transform and Transcend to our investor community, the strategic initiative

Solesence, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026

Solesence, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported revenue was USD 12.96 million compared to USD 14.63 million a year...

Solesence Reports Q1 2026 Results: Full Earnings Call Transcript

Solesence Q1 EPS $(0.01), Sales $12.957M Down From $14.625M YoY

Solesence (NASDAQ:SLSN) reported quarterly losses of $(0.01) per share. The company reported $12.957 million in sales this quarter. This is a 11.41 percent decrease over sales of $14.625 million the same period last